Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Ann Neurol. 2021 Mar 24;89(6):1234–1239. doi: 10.1002/ana.26062

Table 1.

Demographic characteristics, HLA-DR status, serum MOG-IgG and AQP4-IgG positivity according to EBV serostatus.

EBV-VCA IgG negative N=25 EBV-VCA IgG positive N=164 p-value$
Age at first presentation, median (IQR), y 6.7 (4.4–10.8) 14.6 (12.5, 16.0) <0.001
Female, n (%) 17 (68%) 111 (67.7%) 1.00
Race, n (%) 0.20
 White 14 (56%) 110 (67.1%)
 Black 1 (4%) 16 (9.8%)
 Asian 4 (16%) 15 (9.2%)
 Mixed 5 (20%) 20 (12.2%)
 Unknown 1 (4%) 1 (0.6%)
 Pacific Islander 0 2 (1.2%)
Ethnicity, n (%) 0.003
 Hispanic 5 (20%) 77 (47.0%)
 Non-Hispanic 19 (76%) 87 (53.0%)
 Unknown 1 (4%) 0
Positive for DRB1*15:01 or 15:03 4 (16%) 64 (39.0%) 0.019
MOG-IgG positive 11 (44%) 9 (5.5%) <0.001
AQP4-IgG positive 0 0 NA
$

Fisher’s exact test for categorical variables and Wilcoxon rank-sum test for continuous variables.